Skip to main content
Year archive

Active Biotech — 2018 filings

All 38 regulatory filings released by Active Biotech (ACTI) in 2018, sourced directly from the official regulator.

38 Filings
2018 Period
2018 filings (38)
Filing Released Lang
Active Biotech lämnar uppdaterad information om bolagets finansiella ställning
Regulatory Filings
2018-12-10 Swedish
Active Biotech provides updated information about the company's financial position
Capital/Financing Update
2018-12-10 English
Active Biotechs valberedning utsedd
Board/Management Information
2018-11-19 Swedish
Active Biotech's election committee appointed
AGM Information
2018-11-19 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-14 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-11-14 English
Active Biotech: Nya data från fas 2-studien LEGATO-HD presenteras på HSG 2018
Regulatory Filings
2018-11-08 Swedish
Active Biotech: New data from the Phase 2 LEGATO-HD study will be presented at HSG 2018
Regulatory Filings
2018-11-08 English
Active Biotech: Data från fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom presenteras på "European Huntingtons Disease Network (EHDN) plenary meeting 2018"
Regulatory Filings
2018-09-13 Swedish
Active Biotech: Data from the Phase 2 LEGATO-HD study of laquinimod in Huntington's disease will be presented at "European Huntington's Disease Network (EHDN) plenary meeting 2018"
Regulatory Filings
2018-09-13 English
Active Biotech regains global rights to development and commercialization of laquinimod
Regulatory Filings
2018-09-05 English
Active Biotech återtar globala rättigheter till utveckling och kommersialisering av laquinimod
Regulatory Filings
2018-09-05 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-09 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-08-09 English
Active Biotech tillhandahåller uppdatering om laquinimod i Huntingtons sjukdom
Regulatory Filings
2018-07-31 Swedish
Active Biotech provides update on laquinimod in Huntington's disease
Earnings Release FY 2018
2018-07-31 English
Number of shares and votes in Active Biotech
Declaration of Voting Results & Voting Rights Announcements
2018-05-31 English
Antal aktier och röster i Active Biotech
Declaration of Voting Results & Voting Rights Announcements
2018-05-31 Swedish
Årsstämma i Active Biotech AB:
AGM Information
2018-05-18 Swedish
Annual General Meeting of Active Biotech AB
AGM Information
2018-05-18 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-17 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-17 English
Annual Report 2017
Annual Report FY 2017
2018-04-23 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-23 English
Active Biotech: Kallelse till årsstämma
AGM Information
2018-04-18 Swedish
Active Biotech: Notice of Annual General Meeting of Shareholders
AGM Information
2018-04-18 English
Active Biotechs nyemission övertecknad
Share Issue/Capital Change
2018-04-16 Swedish
Active Biotech's rights issue over subscribed
Capital/Financing Update
2018-04-16 English
Active Biotechs samarbetspartner NeoTX presenterar nya data på AACR som visar att ANYARA förstärker effekten av checkpoint-blockad i prekliniska modeller för cancer
Regulatory Filings
2018-04-12 Swedish
Active Biotech's partner NeoTX presents new data at AACR demonstrating that ANYARA enhances the efficacy of checkpoint blockade in preclinical models of cancer
Regulatory Filings
2018-04-12 English
Prospectus relating to Active Biotech's rights issue published
Capital/Financing Update
2018-03-27 English
Prospekt avseende Active Biotechs nyemission offentliggjort
Report Publication Announcement
2018-03-27 Swedish
Extraordinary General Meeting of Active Biotech AB
AGM Information
2018-03-19 English
Extra bolagsstämma i Active Biotech AB
Share Issue/Capital Change
2018-03-19 Swedish
Active Biotech genomför företrädesemission om cirka 48 miljoner kronor
Capital/Financing Update
2018-02-15 Swedish
Active Biotech announces rights issue of approximately SEK 48 million
Share Issue/Capital Change
2018-02-15 English
Earnings Release 2017
Earnings Release FY 2017
2018-02-15 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report FY 2017
2018-02-15 English